Synthesis and In Vivo Hypolipidemic Effect of Some N-(Benzoylphenyl)-Carboxamide Derivatives in Triton WR-1339-Induced Hyperlipidemic Rats
DOI:
https://doi.org/10.1590/s2175-97902022e20007%20Keywords:
Mitochondrial Permeability Transition Pore (mPTP), Mitochondrial Ca2 Uniporter Complex (MCUC), Brain Hemispheres, Kidney Cortex, MedullaAbstract
A series of N-(benzoylphenyl)-carboxamide derivatives (2a, 2b, 3a, 3b, 4a, 4b, 5a, 5b, 6a and 6b) was prepared with good yields by reacting the corresponding carbonyl chlorides with aminobenzophenones at room temperature. This was followed by evaluating the hypotriglyceridemic and hypocholesterolemic effects of 3b, 5a and 5b. Triton WR-1339 (300 mg/kg) was intraperitoneally administered to overnight-fasted rats to induce hyperlipidemia. Rats were divided into six groups: control, hyperlipidemic, hyperlipidemic plus compounds 3b, 5a and 5b and hyperlipidemic plus bezafibrate. Results showed that after 18 h of treatment at a dose of 15 mg/kg body weight of each of the test compounds, the elevated plasma levels of triglycerides (TG) and total cholesterol (TC) were significantly lowered by compounds 5b and 3b (p < 0.001) and by 5a (p < 0.0001), compared to the hyperlipidemic control group. Compounds 3b and 5a significantly increased levels of high-density lipoprotein cholesterol (HDL-C) by 58 and 71%, respectively. In addition, compounds 3b and 5a caused significant reduction (p < 0.0001) of low-density lipoprotein cholesterol (LDL-C) levels compared to the control group. These results suggest a promising potential for compounds 3b, 5a and 5b as lipid-lowering agents, which may contribute to reducing the risk of atherosclerosis and cardiovascular disease.
Downloads
References
Abu Farha R, Bustanji Y, Al-Hiari Y, Al-Qirim T, Abu Shiekha G, Albashiti R. Lipid lowering activity of novel N -(benzoylphenyl)pyridine-3-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats. J Enzyme Inhib Med Chem. 2016;31(4):138-144. https://doi.org/10.1080/14756366.2016.1222581
» https://doi.org/10.1080/14756366.2016.1222581
Al-Najdawi M, Hiari Y, Qirim T, Shattat G, Al-Zweri M, Sheikha GA. Synthesis and Pharmacological Evaluation of Novel Unsubstituted Indole-Anthraquinone Carboxamide Derivatives as Potent Antihyperlipidemic Agents. Zeitschrift Für Naturforsch C. 2014;69(1-2):21-28. https://doi.org/10.5560/znc.2012-0224
» https://doi.org/10.5560/znc.2012-0224
Al-Qirim T, Shattat G, Sweidan K, El-Huneidi W, Sheikha GA, Khalaf RA, et al. In Vivo Antihyperlipidemic Activity of a New Series of N-(Benzoylphenyl) and N-(Acetylphenyl)-1-benzofuran-2-carboxamides in Rats. Arch Pharm (Weinheim). 2012;345(5):401-406.
Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol. 1998;81(4A):7B-12B. https://doi.org/10.1016/S0002-9149(98)00031-9
» https://doi.org/10.1016/S0002-9149(98)00031-9
Bkhaitan MM. Simultaneous determination of simvastatin with caffeine in bulk drug, formulation and their monitoring in mice plasma through HPLC-PDA technique. Curr Anal Chem. 2017;13(6):449-455. https://doi.org/10.2174/1573411013666170721112505
» https://doi.org/10.2174/1573411013666170721112505
Friedman M, Byers SO. Mechanism underlying hypercholesteremia induced by triton WR-1339. Am J Physiol. 1957;190(3):439-445. https://doi.org/10.1152/ajplegacy.1957.190.3.439
» https://doi.org/10.1152/ajplegacy.1957.190.3.439
Ginghina C, Iliescu C. Modern risk stratification in coronary heart disease. J Med Life. 2011;4(4):377-386.
Hamadneh L, Al-Essa L, Hikmat S, Al-Qirim T, Abu Sheikha G, Al-Hiari Y, et al. N-(3-Benzoylphenyl)-1H-Indole-2-Carboxamide decreases triglyceride levels by downregulation of Apoc3 gene expression in acute hyperlipidemic rat model. Mol Cell Biochem. 2017;431(1-2):133-138. https://doi.org/10.1007/s11010-017-2983-3
» https://doi.org/10.1007/s11010-017-2983-3
Harb AA, Bustanji YK, Abdalla SS. Hypocholesterolemic effect of β-caryophyllene in rats fed cholesterol and fat enriched diet. J Clin Biochem Nutr. 2018;62(3):230-237. https://doi.org/10.3164/jcbn.17-3
» https://doi.org/10.3164/jcbn.17-3
Hayashi H, Niinobe S, Matsumoto Y, Suga T. Effects of triton WR-1339 on lipoprotein lipolytic activity and lipid content of rat liver lysosomes. J Biochem. 1981;89(2):573-579. https://doi.org/10.1093/oxfordjournals.jbchem.a133233
» https://doi.org/10.1093/oxfordjournals.jbchem.a133233
Hikmat S, Al-qirim T, Alkabbani D, Shattat G, Sheikha GA, Sabbah D, et al. Synthesis and in vivo anti-hyperlipidemic activity of novel n-benzoylphenyl-2-furamide derivatives in Wistar rats. Trop J Pharm Res. 2017;16(1):193-201. https://doi.org/10.4314/tjpr.v16i1.26
» https://doi.org/10.4314/tjpr.v16i1.26
Jasim SH, Sheikha GMA, Abuzaid HM, Al-Qirim TM, Shattat GF, Sabbah DA, et al. Synthesis and in vivo lipid-lowering activity of novel imidazoles-5-carboxamide derivatives in Triton-WR-1339-induced hyperlipidemic wistar rats. Chem Pharm Bull. 2018;66(10):953-958. https://doi.org/10.1248/cpb.c18-00346
» https://doi.org/10.1248/cpb.c18-00346
Mori Y, Tokutate Y, Oana F, Matsuzawa A, Akahane S, Tajima N. Bezafibrate-Induced Changes over Time in the Expression of Uncoupling Protein (UCP) mRNA in the Tissues: A Study in Spontaneously Type 2 Diabetic Rats with Visceral Obesity. J Atheroscler Thromb. 2004;11(4):224-231. https://doi.org/10.5551/jat.11.224
» https://doi.org/10.5551/jat.11.224
Nakajima T, Tanaka N, Kanbe H, Hara A, Kamijo Y, Zhang X, et al. Bezafibrate at clinically relevant doses decreases serum/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: a novel peroxisome proliferator-activated receptor alpha-independent mechanism. Mol Pharmacol. 2009;75(4):782-792. https://doi.org/10.1124/mol.108.052928
» https://doi.org/10.1124/mol.108.052928
Otway S, Robinson DS. The use of a non-ionic detergent (Triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions. J Physiol. 1967;190(2):321-332.
Parlow JJ, Mischke DA, Woodard SS. Utility of Complementary Molecular Reactivity and Molecular Recognition (CMR/R) Technology and Polymer-Supported Reagents in the Solution-Phase Synthesis of Heterocyclic Carboxamides. J Org Chem. 1997;62(17):5908-5919. https://doi.org/10.1021/jo970571i
» https://doi.org/10.1021/jo970571i
Pérez C, Canal JR, Campillo JE, Romero A, Torres MD. Hypotriglyceridaemic activity of Ficus carica leaves in experimental hypertriglyceridaemic rats. Phyther Res. 1999;13(3):188-191. https://doi.org/10.1002/(SICI)1099-1573(199905)13:3<188::AID-PTR411>3.0.CO;2-P
» https://doi.org/10.1002/(SICI)1099-1573(199905)13:3<188::AID-PTR411>3.0.CO;2-P
Pérez C, Domínguez E, Canal JR, Campillo JE, Torres MD. Hypoglycaemic activity of an aqueous extract from Ficus carica (fig tree) leaves in streptozotocin diabetic rats. Pharm Biol. 2000;38(3):181-186. https://doi.org/10.1076/1388-0209(200007)3831-SFT181
» https://doi.org/10.1076/1388-0209(200007)3831-SFT181
Razali NR, Huri HZ, Ibrahim L, Vethakkan SR, Abdullah BM. Glycemic effects of simvastatin: Where do we stand? Braz J Pharm Sci. 2018;54(1):1-11 https://doi.org/10.1590/s2175-97902018000117192
» https://doi.org/10.1590/s2175-97902018000117192
Da Rocha JT, Sperança A, Nogueira CW, Zeni G. Hypolipidaemic activity of orally administered diphenyl diselenide in Triton WR-1339-induced hyperlipidaemia in mice. J Pharm Pharmacol. 2009;61(12):1673-1679. https://doi.org/10.1211/jpp.61.12.0013
» https://doi.org/10.1211/jpp.61.12.0013
Rohilla A, Dagar N, Rohilla S, Dahiya A, Kushnoor A. Hyperlipidemia-A deadly pathological condition. Int J Curr Pharm Res. 2012;4(3):15-18.
Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med. 1999;341(6):410-418. https://doi.org/10.1056/NEJM199908053410604
» https://doi.org/10.1056/NEJM199908053410604
Saleem Z, Saeed H, Khan ZA, Khan MIH, Hashmi FK, Islam M, et al. Association of hypertension and dyslipidaemia with increasing obesity in patients with type 2 diabetes mellitus. Braz J Pharm Sci . 2019;55:e18136 https://doi.org/10.1590/s2175-97902019000118136
» https://doi.org/10.1590/s2175-97902019000118136
Schotz MC, Scanu A, Page IH. Effect of triton on lipoprotein lipase of rat plasma. Am J Physiol. 1957;188:399-402. https://doi.org/10.1152/ajplegacy.1957.188(2).399-402
» https://doi.org/10.1152/ajplegacy.1957.188(2).399-402
Schurr PE, Schultz JR, Parkinson TM. Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs. Lipids. 1972;7(1):68-74. https://doi.org/10.1007/bf02531272
» https://doi.org/10.1007/bf02531272
Shattat G, Al-Qirim T, Sheikha GA, Al-Hiari Y, Sweidan K, Al-Qirim R, et al. The Pharmacological effects of novel 5-fluoro-N-(9,10-dihydro-9,10- dioxoanthracen-8-yl)-1H-indole-2-carboxamide derivatives on plasma lipid profile of Triton-WR-1339-induced Wistar rats. J Enzyme Inhib Med Chem . 2013;28(4):863-869. https://doi.org/10.3109/14756366.2012.692085
» https://doi.org/10.3109/14756366.2012.692085
Shattat G, Al-Qirim T, Sweidan K, Shahwan M, El-Huneidi W, Al-Hiari Y. The hypolipidemic activity of novel benzofuran-2-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats: a comparison with bezafibrate. J Enzyme Inhib Med Chem . 2010;25(6):751-755. https://doi.org/10.3109/14756360903389880
» https://doi.org/10.3109/14756360903389880
Shattat GF. A review article on hyperlipidemia: Types, treatments and new drug targets. Biomed Pharmacol J. 2014;7(6):399-409. https://doi.org/10.13005/bpj/504
» https://doi.org/10.13005/bpj/504
Sheikha GA, Bkhaitan MM, Kalloush H, Hamadneh L, Khalaf RA, Al-Qirim T, et al. Synthesis of Novel Benzimidazole-2-carboxamide Derivatives and in Vivo Antihyperlipidemic Activity Evaluation. Chem Pharm Bull (Tokyo). 2018;66(4):423-426. https://doi.org/10.1248/cpb.c17-00908
» https://doi.org/10.1248/cpb.c17-00908
Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 1998;98(19):2088-2093. https://doi.org/10.1161/01.CIR.98.19.2088
» https://doi.org/10.1161/01.CIR.98.19.2088
Stancu C, Sima a. Statins: mechanism of action and effects. J Cell Mol Med. 2001;5(4):378-387. https://doi.org/10.1111/j.1582-4934.2001.tb00172.x
» https://doi.org/10.1111/j.1582-4934.2001.tb00172.x
Stapleton Pa, Goodwill AG, James ME, Brock RW, Frisbee JC. Hypercholesterolemia and microvascular dysfunction: interventional strategies. J Inflamm (Lond). 2010;7(1):54-64. https://doi.org/10.1186/1476-9255-7-54
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
